Heart Healthy Ingredients

Heart Healthy Ingredients

Global Heart Healthy Ingredients Market to Reach US$27.0 Billion by 2030

The global market for Heart Healthy Ingredients estimated at US$20.1 Billion in the year 2023, is expected to reach US$27.0 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Omega-3, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Soy Protein segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 7.4% CAGR

The Heart Healthy Ingredients market in the U.S. is estimated at US$5.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Heart Healthy Ingredients Market - Key Trends and Drivers Summarized

The intricate connection between cardiovascular health and dietary choices is increasingly emphasized in modern medical understanding, highlighting the critical role food plays in the prevention and management of cardiovascular disease (CVD). Diets rich in fruits, vegetables, legumes, whole grains, and lean proteins are advocated across global health guidelines while minimizing processed foods, trans fats, and sugar-sweetened beverages. Notable diets such as the Mediterranean, DASH, and various plant-based diets are widely recommended for their proven cardiovascular benefits. These diets are rich in essential nutrients that combat heart disease by reducing blood pressure and mitigating heart disease risks. Emerging research also explores the potential cardiovascular implications of popular regimes like the ketogenic diet and intermittent fasting, which, while beneficial for weight loss, still require more comprehensive studies to verify their long-term cardiovascular impacts.

Advancements in nutritional science reveal the significant influence of diet on the gut microbiome and its consequential effects on heart health, such as the management of cardiometabolic risks through dietary metabolites like trimethylamine N-oxide (TMAO). This evolving field underpins the potential for precision nutrition in revolutionizing CVD management, integrating personalized dietary plans tailored to individual genetic and health profiles. Mediterranean diets, for instance, emphasize foods laden with antioxidants and fibers, such as fruits, vegetables, and whole grains, and healthy fats from fish, nuts, and seeds, which are crucial for maintaining optimal heart health. Moreover, the incorporation of extra virgin olive oil and other plant-based oils enriches these diets with polyphenols and unsaturated fats known for their heart-protective properties.

The market for heart-healthy ingredients is driven by several key factors, including advanced food processing technologies that preserve essential nutrients and bioactive compounds critical for heart health. The rise in functional foods, enriched with cardiovascular-beneficial elements like omega-3 fatty acids and fiber, meets growing consumer demand driven by heightened awareness and education regarding heart health. Additionally, regulatory support for heart-healthy claims, the expanding popularity of plant-based diets, and digital tools that facilitate diet tracking contribute significantly to the adoption of heart-healthy dietary practices. These trends are further bolstered by demographic shifts such as the aging population, emphasizing preventive health measures and the integration of heart-healthy ingredients into regular diets, reflecting a broader societal shift towards proactive health management.

 

 

 

 

 

 

Select Competitors (Total 52 Featured) -

• Andean Grain Products Ltd.
• BASF SE
• Berg Lipidtech AS (BLT)
• Bioriginal Food & Science Corporation
• BTSA Biotecnologias Aplicadas SL
• Croda International Plc.
• Devansoy Inc.
• DuPont de Nemours Inc.
• Eden Foods, Inc.
• FMC Corporation
• Frutarom Industries Ltd.
• Nexira SAS
• Sinomega Biotech Engineering Co., Ltd.
• Tate & Lyle Plc

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.